ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

610 hedge funds and large institutions have $29.1B invested in Alexion Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 263 increasing their positions, 191 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
610
Holders Change
+2
Holders Change %
+0.33%
% of All Funds
13.22%
Holding in Top 10
12
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+50%
% of All Funds
0.26%
New
85
Increased
263
Reduced
191
Closed
75
Calls
$196M
Puts
$221M
Net Calls
-$25.4M
Net Calls Change
-$8.13M

Top Buyers

1
Artisan Partners
Artisan Partners
Wisconsin
$574M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$3.94B
3
Jennison Associates
Jennison Associates
New York
$1.38B
4
TCIM
TIAA CREF Investment Management
New York
$450M
5
Fidelity International
Fidelity International
Bermuda
$163M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$1.91B
2
Sands Capital Management
Sands Capital Management
Virginia
$0
3
Norges Bank
Norges Bank
Norway
$389M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
$22M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ED
676
Exane Derivatives
France
– -$2.34K -24 Closed
PG
677
Patten Group
Tennessee
– -$2K -24 Closed
CA
678
Claro Advisors
Massachusetts
– -$3K -23 Closed
DAM
679
Delta Asset Management
Tennessee
– -$1K -15 Closed
WPA
680
West Paces Advisors
Georgia
– -$974 -10 Closed
24 25 26 27
28